172 related articles for article (PubMed ID: 17523306)
1. Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome.
Maruyama S; Hirayama C; Horie Y; Yorozu K; Maeda K; Inoue M; Fujii Y; Umeki K; Koda M
Hepatogastroenterology; 2007 Mar; 54(74):493-8. PubMed ID: 17523306
[TBL] [Abstract][Full Text] [Related]
2. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of serum IgG, IgA and IgM levels as indicators of hepatic fibrosis in patients with chronic hepatitis C infection].
Ortarık Z; Toyran A; Sen S; Mart Kömürcü SZ; Güvener E
Mikrobiyol Bul; 2011 Apr; 45(2):296-305. PubMed ID: 21644073
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of interferon-treated chronic hepatitis C and serum hepatic fibrosis markers.
Ueno T; Ide T; Hashimoto O; Uchimura Y; Torimura T; Kumashiro R; Inuzuka S; Sata M
Hepatogastroenterology; 2001; 48(40):1124-8. PubMed ID: 11490815
[TBL] [Abstract][Full Text] [Related]
6. Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon.
Ikawa H; Hayashi Y; Ninomiya T; Yano Y; Nakaji M; Nagano H; Seo Y; Kumon Y; Yoon S; Kasuga M; Itoh H; Ohbayashi C
Hum Pathol; 2001 Sep; 32(9):910-7. PubMed ID: 11567219
[TBL] [Abstract][Full Text] [Related]
7. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
[TBL] [Abstract][Full Text] [Related]
8. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse.
Montano-Loza AJ; Carpenter HA; Czaja AJ
Am J Gastroenterol; 2007 May; 102(5):1005-12. PubMed ID: 17319926
[TBL] [Abstract][Full Text] [Related]
9. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection.
Watt K; Uhanova J; Gong Y; Kaita K; Doucette K; Pettigrew N; Minuk GY
J Viral Hepat; 2004 May; 11(3):251-6. PubMed ID: 15117327
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy.
Nguyen HV; Mollison LC; Taylor TW; Chubb SA; Yeap BB
Intern Med J; 2006 Jun; 36(6):362-6. PubMed ID: 16732861
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection.
Schmilovitz-Weiss H; Tovar A; Halpern M; Sulkes J; Braun M; Rotman Y; Tur-Kaspa R; Ben-Ari Z
J Viral Hepat; 2006 Oct; 13(10):671-7. PubMed ID: 16970598
[TBL] [Abstract][Full Text] [Related]
13. Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance.
Yee LJ; Kelleher P; Goldin RD; Marshall S; Thomas HC; Alberti A; Chiaramonte M; Braconier JH; Hall AJ; Thursz MR
J Viral Hepat; 2004 Sep; 11(5):459-64. PubMed ID: 15357653
[TBL] [Abstract][Full Text] [Related]
14. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of intrahepatic HCV RNA level in chronic HCV infection].
Jang JY; Kim YS; Kim SG; Kim YS; Cho YD; Lee JS; Jin SY; Lee MS; Kim JH; Shim CS; Kim BS
Korean J Hepatol; 2006 Dec; 12(4):515-23. PubMed ID: 17237629
[TBL] [Abstract][Full Text] [Related]
16. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C.
Kawaguchi Y; Mizuta T; Oza N; Takahashi H; Ario K; Yoshimura T; Eguchi Y; Ozaki I; Hisatomi A; Fujimoto K
Liver Int; 2009 Jul; 29(6):871-7. PubMed ID: 19302179
[TBL] [Abstract][Full Text] [Related]
17. Liver histology of children with chronic hepatitis treated with interferon-alpha alone or in combination with lamivudine.
Kuloglu Z; Krsaçloglu CT; Kansu A; Erden E; Girgin N
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):564-8. PubMed ID: 18030234
[TBL] [Abstract][Full Text] [Related]
18. Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapy.
Hamano K; Seo Y; Kato H; Kato M; Yano Y; Ninomiya T; Kasuga M
Int J Mol Med; 2006 Jun; 17(6):989-95. PubMed ID: 16685406
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
20. Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology.
Bayram A; Erkilic S; Ozkur A; Bayram M; Sari I
J Clin Pathol; 2008 Mar; 61(3):338-42. PubMed ID: 17693576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]